Vivozon Healthcare Inc (082800) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Vivozon Healthcare Inc (082800) has a cash flow conversion efficiency ratio of -0.020x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.47 Billion ≈ $-995.96K USD) by net assets (₩72.66 Billion ≈ $49.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Vivozon Healthcare Inc - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Vivozon Healthcare Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 082800 total liabilities for a breakdown of total debt and financial obligations.
Vivozon Healthcare Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Vivozon Healthcare Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Eightco Holdings Inc.
NASDAQ:ORBS
|
-0.005x |
|
Shenyang Cuihua Gold and Silver Jewelry Co Ltd
SHE:002731
|
0.045x |
|
Immunic Inc
NASDAQ:IMUX
|
2.889x |
|
Precision Camshafts Limited
NSE:PRECAM
|
0.078x |
|
Empresas Iansa S.A
SN:IANSA
|
0.089x |
|
Enea AB
ST:ENEA
|
0.027x |
|
Onewater Marine
NASDAQ:ONEW
|
-0.275x |
|
Shaniv
TA:SHAN
|
0.079x |
Annual Cash Flow Conversion Efficiency for Vivozon Healthcare Inc (2014–2025)
The table below shows the annual cash flow conversion efficiency of Vivozon Healthcare Inc from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see Vivozon Healthcare Inc (082800) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩72.66 Billion ≈ $49.24 Million |
₩-6.87 Billion ≈ $-4.65 Million |
-0.095x | -275.53% |
| 2024-12-31 | ₩106.43 Billion ≈ $72.12 Million |
₩5.73 Billion ≈ $3.88 Million |
0.054x | +87.33% |
| 2023-12-31 | ₩104.07 Billion ≈ $70.52 Million |
₩2.99 Billion ≈ $2.03 Million |
0.029x | +191.55% |
| 2022-12-31 | ₩105.84 Billion ≈ $71.72 Million |
₩-3.32 Billion ≈ $-2.25 Million |
-0.031x | +84.72% |
| 2021-12-31 | ₩85.12 Billion ≈ $57.68 Million |
₩-17.50 Billion ≈ $-11.86 Million |
-0.206x | -579.12% |
| 2020-12-31 | ₩107.80 Billion ≈ $73.06 Million |
₩4.62 Billion ≈ $3.13 Million |
0.043x | +220.09% |
| 2019-12-31 | ₩109.00 Billion ≈ $73.87 Million |
₩-3.89 Billion ≈ $-2.64 Million |
-0.036x | +46.71% |
| 2018-12-31 | ₩68.45 Billion ≈ $46.38 Million |
₩-4.59 Billion ≈ $-3.11 Million |
-0.067x | +76.48% |
| 2017-12-31 | ₩16.10 Billion ≈ $10.91 Million |
₩-4.59 Billion ≈ $-3.11 Million |
-0.285x | -210.44% |
| 2016-12-31 | ₩22.74 Billion ≈ $15.41 Million |
₩5.87 Billion ≈ $3.98 Million |
0.258x | +128.52% |
| 2015-12-31 | ₩24.65 Billion ≈ $16.71 Million |
₩2.78 Billion ≈ $1.89 Million |
0.113x | +26.48% |
| 2014-12-31 | ₩33.90 Billion ≈ $22.97 Million |
₩3.03 Billion ≈ $2.05 Million |
0.089x | -- |
About Vivozon Healthcare Inc
Vivozon Pharmaceutical Co., Ltd. researches, develops, produces, and sells LED products primarily in South Korea. The company offers LED packages for interior, general, indoor, decorative, and automotive lighting, as well as display applications. It also provides LED set linear lamps, including panel lamps, down lights, and flood lights for residential, commercial, and industrial structures, as w… Read more